Société Generex Biotechnology Corporation
Actions
GNBT
US3714853013
Recherche biotechnologique et médicale
Métier
Ventes par activité
USD en Millions | 2019 | Poids | 2020 | Poids | Delta |
---|---|---|---|---|---|
Drug Delivery Systems and Technologies
99,3
%
| - | - | 3 | 99,3 % | - |
Management Services
0,7
%
| - | - | 0 | 0,7 % | - |
Ventes par région
USD en Millions | 2019 | Poids | 2020 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 6 | 100,0 % | 3 | 100,0 % | -57,10% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joseph Moscato
CEO | Chief Executive Officer | 61 | 21/11/17 |
Mark Carrao
DFI | Director of Finance/CFO | - | 01/01/17 |
Terry Thompson
COO | Chief Operating Officer | 65 | 25/06/18 |
Andrew Ro
CIO | Chief Investment Officer | 54 | 21/11/17 |
Chief Administrative Officer | 54 | 12/10/18 | |
Jason Terrell
CTO | Chief Tech/Sci/R&D Officer | 43 | 01/02/17 |
General Counsel | - | 12/02/19 | |
Michelle Starr
SAM | Sales & Marketing | - | 08/01/19 |
Corporate Officer/Principal | - | 08/01/19 | |
Eric von Hofe
PRN | Corporate Officer/Principal | 66 | 01/01/05 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Brian T. McGee
BRD | Director/Board Member | 63 | 01/03/04 |
Eric von Hofe
PRN | Corporate Officer/Principal | 66 | 01/01/05 |
Craig Eagle
BRD | Director/Board Member | 57 | 21/11/17 |
Joseph Moscato
CEO | Chief Executive Officer | 61 | 21/11/17 |
Andrew Ro
CIO | Chief Investment Officer | 54 | 21/11/17 |
Director/Board Member | 73 | 08/04/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 122 058 444 | 122 058 444 ( 100,00 %) | 0 | 100,00 % |
Coordonnées société
Secteur
Ventes par activité
Varia. 1 janv. | Capi. | |
---|---|---|
+2,97% | 108 Md | |
+10,21% | 104 Md | |
+2,13% | 22,33 Md | |
-12,77% | 22,19 Md | |
-7,05% | 18,69 Md | |
-37,64% | 17,74 Md | |
-6,50% | 17,64 Md | |
+6,00% | 14,05 Md | |
+37,20% | 12,51 Md |